Sorrento Therapeutics Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical stage, antibody-centric …
Sorrento Therapeutics Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical stage, antibody-centric …